Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Bedaquiline
Other

Bedaquiline

Tracked across 1 events · 6 articles · First seen Feb 12, 2026 · Last active Feb 13, 2026

Sentiment
70
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 70
Tech
India TB Regimen Cost-Effective Study
Impact: Bedaquiline is a key component of the new, cost-effective regimens (BPaL and BPaLM) for multidrug-resistant and rifampicin-resistant tuberculosis.
Feb 12, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Bedaquiline live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.